Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Caribou Biosciences, Inc. | d145328ds1a.htm |
| EX-10.41 - EX-10.41 - Caribou Biosciences, Inc. | d145328dex1041.htm |
| EX-10.46 - EX-10.46 - Caribou Biosciences, Inc. | d145328dex1046.htm |
| EX-10.45 - EX-10.45 - Caribou Biosciences, Inc. | d145328dex1045.htm |
| EX-10.40 - EX-10.40 - Caribou Biosciences, Inc. | d145328dex1040.htm |
| EX-10.38 - EX-10.38 - Caribou Biosciences, Inc. | d145328dex1038.htm |
| EX-10.34 - EX-10.34 - Caribou Biosciences, Inc. | d145328dex1034.htm |
| EX-10.30 - EX-10.30 - Caribou Biosciences, Inc. | d145328dex1030.htm |
| EX-10.19 - EX-10.19 - Caribou Biosciences, Inc. | d145328dex1019.htm |
| EX-5.1 - EX-5.1 - Caribou Biosciences, Inc. | d145328dex51.htm |
| EX-3.5 - EX-3.5 - Caribou Biosciences, Inc. | d145328dex35.htm |
| EX-3.3 - EX-3.3 - Caribou Biosciences, Inc. | d145328dex33.htm |
| EX-3.2 - EX-3.2 - Caribou Biosciences, Inc. | d145328dex32.htm |
| EX-1.1 - EX-1.1 - Caribou Biosciences, Inc. | d145328dex11.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Amendment to the Registration Statement No. 333-257604 on Form S-1 of our report dated May 7, 2021 (July 19, 2021 as to the effects of the stock split described in Note 2 and Note 15), relating to the financial statements of Caribou Biosciences, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
San Francisco, California
July 19, 2021